• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

157.5210 USD 2.2590 1.41%

As of 13:08:47 ET on 09/30/2014.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 159.7900 High - Low: 159.8000 - 156.6100 Primary Exchange: NYSE Arca
Volume: 129,504 52-Week Range: 113.2201 - 172.5240 Beta vs SPSIBITR: 1.0001

ETF Chart for XBI

No chart data available.
  • XBI:US 157.4900
  • 1D
  • 1M
  • 1Y
159.7800
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2014-09-29) 159.8873
Assets (M) (on 2014-09-29) 1,231.1320
Shares out (M) 7.70
Market Cap (M) 1,211.90
% Premium -0.07
Average 52-Week % Premium -0.0127
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.5628
Dividend Yield (ttm) 0.98%

Performance for XBI

1-Month -0.99% 1-Year +23.02%
3-Month +4.48% 3-Year +38.82%
Year To Date +23.92% 5-Year +24.45%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 09/29/2014
Name Position Value % of Total
Agios Pharmaceuticals Inc 351,218 23,355,997 1.923%
PTC Therapeutics Inc 474,637 21,652,940 1.783%
Vertex Pharmaceuticals Inc 167,070 19,029,273 1.567%
Acorda Therapeutics Inc 508,709 18,155,824 1.495%
AMAG Pharmaceuticals Inc 608,227 18,076,506 1.488%
Merrimack Pharmaceuticals Inc 2,136,418 17,988,640 1.481%
Receptos Inc 260,334 16,963,363 1.397%
Alnylam Pharmaceuticals Inc 214,116 16,829,518 1.386%
Repligen Corp 831,434 16,711,823 1.376%
BioMarin Pharmaceutical Inc 228,416 16,674,368 1.373%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil